Proinflammatory and cardiovascular biomarkers are associated with echocardiographic abnormalities in children with HIV taking antiretroviral therapy
- PMID: 36001499
- PMCID: PMC7614876
- DOI: 10.1097/QAD.0000000000003368
Proinflammatory and cardiovascular biomarkers are associated with echocardiographic abnormalities in children with HIV taking antiretroviral therapy
Abstract
Objectives: Children with perinatally acquired HIV (PHIV) and taking antiretroviral therapy (ART) have a high prevalence of subclinical cardiac disease. We hypothesized that cardiac disease may be a consequence of dysregulated systemic immune activation driven by HIV infection. We examined cardiovascular and proinflammatory biomarkers and their association with echocardiographic abnormalities in children with PHIV.
Design: Cross-sectional analysis of soluble biomarkers from a prospective cohort of children aged 6-16 years with PHIV and age-matched HIV-uninfected comparison group.
Methods: Cryopreserved plasma samples were used to measure seven soluble biomarkers using multiplex bead assay (Luminex). Multivariable logistic regression assessed how biomarker levels related to cardiac abnormalities.
Results: A total of 406 children participated in this study (195 PHIV and 211 HIV-uninfected). Mean [standard deviation (SD)] ages of PHIV and HIV-uninfected participants were 10.7 (2.6) and 10.8 (2.8) years, respectively. Plasma levels of CRP, TNF-α, ST2, VCAM-1 and GDF-15 were significantly higher in the PHIV group compared with uninfected control ( P < 0.001). Among children with PHIV, with one-unit representing one SD in biomarker level, a one-unit increase in CRP and GDF-15, was associated with increased odds of having left ventricular (LV) diastolic dysfunction [adjusted odds ratio (aOR), 1.49 (1.02-2.18; P < 0.040)] and [aOR 1.71 (1.18-2.53; P = 0.006)], respectively. Each one unit increase in GDF-15 was associated with increased odds of LV hypertrophy [aOR 1.84 (95% CI 1.10-3.10; P < 0.021)].
Conclusion: Children with PHIV had higher levels of proinflammatory and cardiovascular biomarkers compared with HIV-uninfected children. Increased CRP and GDF-15 were associated with cardiac abnormalities in children with PHIV.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Figures


References
-
- Al-Attar, Orav JE, Exil V, Vlach SA, Lipshultz S. Predictors of Cardiac Morbidity and Related Mortality in Children With Acquired Immunodeficiency Syndrome. Journal of the American College of Cardiology. 2003;41(9):1598–605. - PubMed
-
- Herskowitz A. Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. Current opinion in cardiology. 1996;11(3):325–31. - PubMed
-
- Luginbuhl LM, Orav E, McIntosh K, Lipshultz SE. Cardiac morbidity and related mortality in children with hiv infection. Jama. 1993;269(22):2869–75. - PubMed
-
- Stewart JM, Kaul A, Gromisch DS, Reyes E, Woolf PK, Gowitz MH. Symptomatic cardiac dysfunction in children with human immunodeficiency virus infection. American heart journal. 1989;117(1):140–4. - PubMed
-
- Cerrato E, D’Ascenzo F, Biondi-Zoccai G, Calcagno A, Frea S, Grosso Marra W, et al. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J. 2013;34(19):1432–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous